Perspective Therapeutics (CATX) Treasury Shares (2011 - 2015)
Perspective Therapeutics' (CATX) quarterly Treasury Shares came in at $8390.0 in Q4 2015, little changed quarter-over-quarter from $8390.0 in Q2 2015.
Powered by 
Analysis
Perspective Therapeutics (CATX) Treasury Shares (2011 - 2015) Analysis & Trends
Perspective Therapeutics has disclosed Treasury Shares across 5 years of filings, most recently posting $8390.0 for Q4 2015.
- In Q4 2015, Treasury Shares changed N/A year-over-year to $8390.0; the TTM figure through Dec 2015 stood at $8390.0 (changed N/A YoY), while the FY2015 annual figure was $8390.0, changed 0.0% from the prior year.
- Treasury Shares came in at $8390.0 for Q4 2015 at Perspective Therapeutics, roughly flat from $8390.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $13200.0 in Q2 2011 to a low of $13200.0 in Q2 2011.
- Average Treasury Shares over 5 years is $13200.0, with a median of $13200.0 recorded in 2011.
- The largest YoY upside for Treasury Shares was 0.0% in 2012 against a maximum downside of 0.0% in 2012.
- Over 5 years, Treasury Shares stood at $8390.0 in 2011, then changed by 0.0% to $8390.0 in 2012, then changed by 0.0% to $8390.0 in 2013, then changed by 0.0% to $8390.0 in 2014, then changed by 0.0% to $8390.0 in 2015.
- Per Business Quant data, the three most recent Treasury Shares figures were $8390.0 in Q4 2015, $8390.0 in Q2 2015, and $8390.0 in Q2 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 36.40 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | -23.80 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Perspective Therapeutics | 361.95 Mn | 361.95 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 13,200.00 |
| Dec 31, 2015 | 8,390.00 |
| Dec 31, 2015 | 13,200.00 |
| Dec 31, 2015 | 8,390.00 |
| Sep 30, 2015 | 13,200.00 |
| Sep 30, 2015 | 13,200.00 |
| Jun 30, 2015 | 8,390.00 |
| Jun 30, 2015 | 8,390.00 |
| Jun 30, 2015 | 13,200.00 |
| Jun 30, 2015 | 13,200.00 |
| Mar 31, 2015 | 13,200.00 |
| Mar 31, 2015 | 13,200.00 |
| Dec 31, 2014 | 13,200.00 |
| Dec 31, 2014 | 13,200.00 |
| Sep 30, 2014 | 13,200.00 |
| Sep 30, 2014 | 13,200.00 |
| Jun 30, 2014 | 8,390.00 |
| Jun 30, 2014 | 8,390.00 |
| Jun 30, 2014 | 13,200.00 |
| Jun 30, 2014 | 13,200.00 |